• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE PS FEM LT SZ 6 CEM; ATTUNE IMPLANT : KNEE FEMORAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE PS FEM LT SZ 6 CEM; ATTUNE IMPLANT : KNEE FEMORAL Back to Search Results
Model Number 1504-10-106
Device Problem Loss of or Failure to Bond (1068)
Patient Problems Pain (1994); Loss of Range of Motion (2032); Synovitis (2094); Osteolysis (2377); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 12/20/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Initial report: patient was revised to address loosening of the tibial component at cement to implant interface.Cement manufacturer was unknown.There was no cement bond to implant.Doi: (b)(6) 2014 dor: (b)(6) 2018 left knee.Further information received (b)(6) 2021 and reviewed: patient received a left primary attune tka to treat pain secondary to tricompartmental osteoarthritis.The patella was resurfaced and depuy smartset gentamycin cement x2 was utilized.The procedure was completed without complications.The surgeon notes that the patient has morbid obesity.Patient received a left knee revision to treat pain, impaired mobility, and osteolysis secondary to aseptic loosening.Upon entering the joint, the surgeon identified and excised periarticular synovitis.The surgeon notes there was femoral condyle and tibial metaphyseal osteolysis.The femoral component was loosened at an unknown interface and revised.The tibial tray was grossly loose and debonded at the cement to implant interface.The surgeon notes there was some femoral condyle and tibial metaphyseal bone loss.There was no reported product problem with the revised tibial insert.The patella was well-fixed and retained.The patient was revised with a depuy sigma revision construct utilizing depuy cement x 3.The procedure was completed without complications.Doi: (b)(6) 2014.Dor: (b)(6) 2018.Left knee.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Device history lot : the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE PS FEM LT SZ 6 CEM
Type of Device
ATTUNE IMPLANT : KNEE FEMORAL
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
MDR Report Key11334745
MDR Text Key232126478
Report Number1818910-2021-03124
Device Sequence Number1
Product Code OIY
UDI-Device Identifier10603295041634
UDI-Public10603295041634
Combination Product (y/n)N
PMA/PMN Number
P830055
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup
Report Date 02/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/01/2023
Device Model Number1504-10-106
Device Catalogue Number150410106
Device Lot Number349107
Was Device Available for Evaluation? No
Date Manufacturer Received04/03/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATTUNE FB TIB BASE SZ 5 CEM; ATTUNE MEDIAL DOME PAT 38MM; ATTUNE PS FB INSRT SZ 6 8MM; SMARTSET GMV 40G US EO; SMARTSET GMV 40G US EO; ATTUNE FB TIB BASE SZ 5 CEM; ATTUNE MEDIAL DOME PAT 38MM; ATTUNE PS FB INSRT SZ 6 8MM; SMARTSET GMV 40G US EO; SMARTSET GMV 40G US EO
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-